Title |
Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus
|
---|---|
Published in |
Molecular Neurodegeneration, June 2011
|
DOI | 10.1186/1750-1326-6-41 |
Pubmed ID | |
Authors |
Gurdeep Marwarha, Jaya RP Prasanthi, Jared Schommer, Bhanu Dasari, Othman Ghribi |
Abstract |
Evidence shows that the insulin-like growth factor-1 (IGF-1) and leptin reduce β-amyloid (Aβ) production and tau phosphorylation, two major hallmarks of Alzheimer's disease (AD). IGF-1 expression involves the JAK/STAT pathway and the expression of leptin is regulated by the mammalian target of rapamycin complex 1 (mTORC1). We have previously shown that Aβ reduces leptin by inhibiting the mTORC1 pathway and Aβ was also suggested to inhibit the JAK/STAT pathway, potentially attenuating IGF-1 expression. As IGF-1 can activate mTORC1 and leptin can modulate JAK/STAT pathway, we determined the extent to which IGF-1 and leptin can upregulate the expression of one another and protect against Aβ-induced downregulation. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 35% |
Student > Doctoral Student | 3 | 9% |
Researcher | 3 | 9% |
Professor > Associate Professor | 3 | 9% |
Student > Bachelor | 3 | 9% |
Other | 5 | 15% |
Unknown | 5 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 14 | 41% |
Biochemistry, Genetics and Molecular Biology | 4 | 12% |
Medicine and Dentistry | 4 | 12% |
Neuroscience | 3 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Other | 0 | 0% |
Unknown | 7 | 21% |